Volume 62, Issue 4, Pages (October 2002)

Slides:



Advertisements
Similar presentations
Breast Cancer Risk in Usual Ductal Hyperplasia Is Defined by Estrogen Receptor-α and Ki-67 Expression  Abeer M. Shaaban, John P. Sloane, Christopher R.
Advertisements

Volume 57, Issue 2, Pages (October 2000)
Volume 62, Issue 4, Pages (October 2002)
Volume 60, Issue 6, Pages (December 2001)
Volume 64, Issue 3, Pages (September 2003)
Effects of testosterone, dihydrotestosterone, and 17β-estradiol on human ovarian tissue survival in culture  Marjut Otala, M.Sc., Sirpa Mäkinen, M.Sc.,
Volume 67, Issue 5, Pages (May 2005)
Osteopontin expression in acute renal allograft rejection
Renal vitamin D receptor expression and vitamin D renoprotection
Volume 68, Issue 6, Pages (December 2005)
FGF23 or PTH: which comes first in CKD ?
The Case ∣ Acute renal failure and anemia
C-reactive protein and dialysis access
Volume 67, Issue 6, Pages (June 2005)
Volume 78, Issue 10, Pages (November 2010)
Volume 58, Issue 1, Pages (July 2000)
Volume 74, Issue 1, Pages (July 2008)
Volume 67, Issue 2, Pages (February 2005)
FGF23–parathyroid interaction: implications in chronic kidney disease
Volume 128, Issue 5, Pages (May 2005)
Volume 63, Issue 1, Pages (January 2003)
Sayu Omori, Ryuji Fukuzawa, Mariko Hida, Midori Awazu 
Volume 62, Issue 4, Pages (October 2002)
C-reactive protein and dialysis access
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Volume 57, Issue 2, Pages (October 2000)
Donna R Session, M. D. , Michael P Fautsch, Ph. D
Volume 60, Issue 6, Pages (December 2001)
Volume 55, Issue 4, Pages (April 1999)
Volume 70, Pages S12-S15 (July 2006)
Volume 77, Issue 9, Pages (May 2010)
M. Svensson, H. Irjala, C. Svanborg, G. Godaly  Kidney International 
Volume 60, Issue 5, Pages (November 2001)
Volume 72, Issue 5, Pages (September 2007)
The new role of calcimimetics as vasculotropic agents
Use of vitamin D in chronic kidney disease patients
Florian Lang, Michael Föller  Kidney International 
Excessive ovarian response is associated with increased expression of interleukin-2 in the periimplantation endometrium  Guneet Makkar, Ph.D., Ernest.
The calcium–phosphorus in guidelines for CKD-MBD
Volume 63, Issue 4, Pages (April 2003)
Volume 57, Issue 2, Pages (October 2000)
Volume 55, Issue 1, Pages (January 1999)
Yuan-Yow Chiou, Chi-Chang Shieh, Hong-Lin Cheng, Ming-Jer Tang 
Expression of connective tissue growth factor in human renal fibrosis
Volume 72, Issue 8, Pages (October 2007)
Volume 80, Issue 5, Pages (September 2011)
Volume 87, Issue 3, Pages (March 2015)
Volume 59, Issue 3, Pages (March 2001)
Pathogenic mechanisms for parathyroid hyperplasia
Volume 56, Issue 4, Pages (October 1999)
Pathogenesis of refractory secondary hyperparathyroidism
Acute kidney failure with renal carcinomatous lymphangitis secondary to advanced colon cancer  Thomas Robert, Anissa Moktefi, Helge Wiig, Isabelle Brochériou,
Volume 75, Issue 9, Pages (May 2009)
Parathyroid growth and regression in experimental uremia
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics  William G. Goodman, L.D. Quarles 
Volume 26, Issue 2, Pages (June 2019)
Volume 80, Issue 10, Pages (November 2011)
Increased parathyroid expression of klotho in uremic rats
Volume 74, Issue 9, Pages (November 2008)
The Case | Peculiar fibrous nodules in a renal transplant biopsy
Volume 57, Issue 2, Pages (October 2000)
Cheryl P. Sanchez, Yu-Zhu He, Ellen Leiferman, Norman J. Wilsman 
Tissue protection by erythropoietin: new findings in a moving field
Volume 60, Issue 5, Pages (November 2001)
Volume 55, Issue 4, Pages (April 1999)
Volume 61, Issue 4, Pages (April 2002)
Volume 87, Issue 6, Pages (June 2015)
 (A) Parathyroid imprint cytology showing the typical evenly stained round nuclei (May-Grünwald-Giemsa stain).  (A) Parathyroid imprint cytology showing.
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 62, Issue 4, Pages 1196-1207 (October 2002) Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism1  Masanori Tokumoto, Kazuhiko Tsuruya, Kyoichi Fukuda, Hidetoshi Kanai, Shoji Kuroki, Hideki Hirakata  Kidney International  Volume 62, Issue 4, Pages 1196-1207 (October 2002) DOI: 10.1111/j.1523-1755.2002.kid585.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Representative microscopic findings of parathyroid gland tissues in each group (H&E stain, ×200). (A) Normal parathyroid gland is composed of chief cells, oxyphilic cells, and stromal fat cells. (B) Parathyroid adenoma is surrounded with compressed rim of normal parathyroid containing numerous stromal fat cells. (C) Diffuse parathyroid hyperplasia is characterized by cell proliferation with normal lobular constitution. (D) Nodular parathyroid hyperplasia is comprised of several nodules surrounded by fibrous capsules. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Representative immunohistochemical findings of vitamin D receptor (VDR) protein expression in parathyroid gland tissues with diaminobenzidine chromogen and hematoxylin counterstain (×400). (A) Normal parathyroid gland with nearly all nuclei showing brown staining for VDR protein. (B) Parathyroid adenoma with some nuclei staining for VDR. (C) Diffuse parathyroid hyperplasia with the majority of nuclei staining for VDR. (D) Nodular parathyroid hyperplasia with few nuclei staining for VDR. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Difference in the mean labeling index (LI) of vitamin D receptor (VDR) protein expression among each histological type of parathyroid glands. Nodular parathyroid hyperplasia (HP) shows the lowest VDR LI. *P < 0.01 vs. normal; **P < 0.01 vs. diffuse HP; ***P < 0.01 vs. adenoma. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Representative immunohistochemical findings of p21 protein expression in parathyroid gland tissues with diaminobenzidine chromogen and hematoxylin counterstain (×400). (A) Normal parathyroid gland. Nearly all nuclei show brown staining for p21 protein. (B) Parathyroid adenoma. Some nuclei show positive staining for p21. (C) Diffuse parathyroid hyperplasia. The majority of nuclei show positive staining for p21. (D) Nodular parathyroid hyperplasia. Only few nuclei show positive staining for p21. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Difference in the mean labeling index (LI) of p21 protein expression among each histological type of parathyroid glands. Nodular hyperplasia (HP) and adenoma show the lowest p21 LI. *P < 0.01 vs. normal; **P < 0.01 vs. diffuse HP. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Representative immunohistochemical findings of expression of p21 and VDR in serial sections of diffuse hyperplastic parathyroid gland tissues showing early nodular formation with diaminobenzidine chromogen and hematoxylin counterstain (×200). (A) Nuclear VDR expression. The majority of nuclei are stained strongly with VDR protein in the left side, but only a small number of nuclei show positive staining in the right side. (B) p21 expression. Immunohistochemistry for p21 expression show positive staining in the nuclei of the left side, which is the same as the VDR expression. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 7 Correlation between the labeling index of VDR expression (VDR LI) and that of p21 (p21 LI) only in nodular hyperplasia. A significant positive correlation is found between VDR LI and p21 LI in nodular hyperplasia: y = 1.2 + 0.52x; r = 0.915, P < 0.01. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 8 Correlation between the labeling index of p21 expression (p21 LI) and the weight of parathyroid gland only in nodular hyperplasia. A significant negative correlation was found between p21 LI and the weight of parathyroid gland in nodular hyperplasia: y = 2.0 - 0.007x; r = 0.442, P < 0.05. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 9 Representative immunohistochemical findings of p27 protein expression in parathyroid gland tissues with diaminobenzidine chromogen and hematoxylin counterstain (×400). (A) Normal parathyroid gland. Nearly all nuclei show brown staining for p27 protein. (B) Parathyroid adenoma. Some nuclei show positive staining for p27. (C) Diffuse parathyroid hyperplasia. The majority of nuclei show positive staining for p27. (D) Nodular parathyroid hyperplasia. Only few nuclei show positive staining for p27. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 10 Differences in the mean labeling index (LI) of p27 protein expression among each histological type of parathyroid glands. Nodular hyperplasia (HP) and adenoma show the lowest p21 LI. *P < 0.01 vs. normal; **P < 0.01 vs. diffuse HP. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 11 Representative immunohistochemical findings p27 and VDR expression in the serial sections of diffuse hyperplastic parathyroid gland tissues, which show early nodular formation with diaminobenzidine chromogen and hematoxylin counterstain (×200). (A) Nuclear VDR expression. The majority of nuclei are stained strongly with VDR protein expression on the lower side, but only a small number of nuclei show positive staining in the upper side (×200). (B) p27 expression shows positive staining in the nuclei of the lower side, the same as VDR expression. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 12 Correlation between the labeling index of VDR expression (VDR LI) and that of p27 (p27 LI) only in nodular hyperplasia. A significant positive correlation was found between VDR LI and p27 LI in nodular hyperplasia: y = 15.4 + 0.65x; r = 0.76, P < 0.01. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 13 Correlation between the labeling index of p27 expression (p27 LI) and the weight of parathyroid gland only in nodular hyperplasia. A significant negative correlation was found between p27 LI and the weight of parathyroid gland in nodular hyperplasia: y = 1.99 - 0.005x; r = 0.41, P < 0.05. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 14 Immunohistochemical findings of Ki67 antigen in parathyroid gland tissues with diaminobenzidine chromogen and hematoxylin counterstain (×400). (A) Normal parathyroid gland: A few nuclei showed brown staining for Ki67 antigen. (B) Parathyroid adenoma: A majority of the nuclei showed positive staining for Ki67. (C) Diffuse parathyroid hyperplasia: In this figure, only 2 nuclei showed positive staining for Ki67. (D) Nodular parathyroid hyperplasia: Some nuclei showed positive staining for Ki67, but the incidence was less as compared to adenoma. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 15 Difference in the mean labeling index of Ki67 expression (Ki67 LI) among each histological type of parathyroid glands. Both adenoma and nodular hyperplasia (HP) showed a significantly higher ki67 LI. *P < 0.01 vs. normal; **P < 0.01 vs. diffuse HP. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 16 Representative immunohistochemical findings of p53 expression in parathyroid gland tissues with diaminobenzidine chromogen and hematoxylin counterstain. (A) Normal parathyroid gland where a few nuclei are stained brown for p53 protein. (B) Parathyroid adenoma; the majority of nuclei show positive staining for p53. (C) Diffuse parathyroid hyperplasia, showing a few nuclei that have a positive staining for p53. (D) Nodular parathyroid hyperplasia where a few nuclei show positive staining for p53, the same as that in the diffuse hyperplasia. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 17 Difference in the mean labeling index of p53 expression (p53 LI) among each histological type of parathyroid glands. Parathyroid adenoma shows the highest p53 LI. Interestingly, no up-regulation of p53 is found in any of the hyperplastic glands. *P < 0.01 vs. normal; **P < 0.01 vs. diffuse hyperplasia (HP); ***P < 0.01 vs. nodular HP. Kidney International 2002 62, 1196-1207DOI: (10.1111/j.1523-1755.2002.kid585.x) Copyright © 2002 International Society of Nephrology Terms and Conditions